Objective
- To determine whether geographical variation in type 1 diabetes incidence across Europe reflects differences in prevalence of genes confirming susceptibility or protection to the disease.
- To establish whether the pattern of autoantibodies in newly diagnosed patients with type 1 diabetes varies across Europe, and if so, whether this is related to differences in the prevalence of genes confirming susceptibility to the disease.
- To estimate the absolute risk of type 1 diabetes associated with markers of genetic susceptibility and immune markers of risk in European populations with different background risk of the disease.
- To determine whether there is heterogeneity in genotype and autoantibodies according to age at diagnosis.
- To investigate the aetiological role of a potential non-genetic determinant, namely Coxsackie B virus infection, with particular attention to the associations between Coxsackie B virus antibodies, islet autoantibodies at diagnosis and genotype.
EURODIAB ACE, an ongoing Concerted Action, has demonstrated a more than 10-fold difference in the risk of type 1 diabetes across Europe, implying that Europe represents a unique setting for research into the aetiology of type 1 diabetes. The existing registration network of new (incident) cases of type 1 diabetes will provide the prospective epidemiological sampling framework of probands and their families for intensive genetic and immune markers. The network comprises 44 centres from 28 European nations, covering 25-30% of all European children and producing about 2800 new cases of childhood-onset type 1 diabetes annually. In addition, some 1350 new cases with onset in the age group 15-29 years will be registered annually from 12 centres. From selected centres, characterized by different levels of population risk of type 1 diabetes, about 2000 cases and their nuclear family members, totalling about 8000 individuals, will be sampled for detailed investigations. Leading expert laboratories in advanced molecular genetics and immunology will provide laboratory support, organized in the new Concerted Action, PARADIGM.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences molecular biology molecular genetics
- natural sciences biological sciences microbiology virology
- medical and health sciences health sciences public health epidemiology
- medical and health sciences clinical medicine endocrinology diabetes
- medical and health sciences basic medicine immunology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
5000 Odense C
Denmark
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.